Autophagy represents a new frontier of drug discovery. Casma is building a team of dedicated individuals who share a passion to advance new treatments to cure challenging diseases while creating a culture of trust, risk-taking and teamwork.”
Keith Dionne, Ph.D.
Chief Executive Officer
New discoveries are revealing the fundamental role of autophagy and lysosomal flux in maintaining cellular health. Furthermore, it is now appreciated that inadequate or aberrant autophagy contributes to a wide range of diseases. We are focused on boosting autophagy – pioneering novel therapeutic strategies to address unmet medical needs. We are creating a new target set for drug discovery and development, and advancing innovative paradigms to treat a broad set of illnesses that are either neglected or inadequately addressed today.
Our growing team is driven to transform fundamental discoveries on autophagy into promising therapeutic medicines.